​​​​

 

 

Electronic transmission of individual case safety reportshttps://legemiddelverket.no/english/pharmacovigilance/electronic-transmission-of-individual-case-safety-reportsElectronic transmission of individual case safety reports As of November 2005 the Norwegian Medicines Agency (NOMA) only accepts individual case safety reports (ICSRs) electronically through Eudravigilance gateway. 438
Frequently asked questions (FAQ) – Electronic transmission of individual case safety reportshttps://legemiddelverket.no/english/pharmacovigilance/frequently-asked-questions-faq-electronic-transmission-of-individual-case-safety-reportsFrequently asked questions (FAQ) – Electronic transmission of individual case safety reportsThis information is meant as guidance on specific topics, and reflects frequently asked questions from the marketing authorisation holders (MAHs). 439
Questions and answers about the introduction of the new pharmacovigilance legislationhttps://legemiddelverket.no/english/pharmacovigilance/questions-and-answers-about-the-introduction-of-the-new-pharmacovigilance-legislationQuestions and answers about the introduction of the new pharmacovigilance legislation440
What is pharmacovigilancehttps://legemiddelverket.no/english/pharmacovigilance/what-is-pharmacovigilanceWhat is pharmacovigilancePharmacovigilance is an important tool for ensuring safe and effective drugs. The purpose is to gather information about safety in clinical use and shorten the time until the safety profile of a drug is well known.437